Hoyoung Huh
Chief Operating Officer, Nektar Therapeutics.
Companies
- Akari Therapeutics PlcBoard member Nov 22, 2024 to now1
- Pliant (United States)Board member Jun 2, 2020 to now2
- Peak Bio, Inc.Board member Nov 3, 2022 to Nov 18, 20243
- CytomX Therapeutics, Inc.Board member Jun 14, 2016 to Jun 15, 20184
- Geron CorporationBoard member May 21, 2010 to May 17, 20185
- Rezolute, Inc.Chair Jan 18, 2017 to Jan 18, 20176
- Rezolute, Inc.Board member Feb 8, 2013 to May 2, 20147
- Geron CorporationChair May 24, 2011 to May 24, 20118
- Nektar TherapeuticsBoard member Mar 5, 2008 to Dec 4, 20089
- Nektar TherapeuticsChief operating officer May 29, 2007 to Dec 26, 200710
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Akari Therapeutics Plc AKTX4,805,311 shares11$40.2M at $8.37Mar 24, 2025
- Peak Bio, Inc.0 shares12Nov 14, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 6, 2025Granted 892,857 shares at $1.12 of Akari Therapeutics Plc13
- Nov 14, 2024Returned to company 372,940 shares of Peak Bio, Inc.12
- Nov 14, 2024Returned to company 8,382,742 shares of Peak Bio, Inc.12
- Nov 14, 2024Returned to company 4,574,661 shares of Peak Bio, Inc.12
- Nov 14, 2024Converted 4,574,661 shares of Peak Bio, Inc.12
- Sep 21, 2023Bought 45,000 shares of Peak Bio, Inc.14
- Sep 20, 2023Bought 30,000 shares of Peak Bio, Inc.15
- Sep 19, 2023Bought 50,000 shares of Peak Bio, Inc.15
- Sep 15, 2023Bought 25,000 shares of Peak Bio, Inc.16
- Sep 14, 2023Bought 20,000 shares of Peak Bio, Inc.17
- Sep 13, 2023Bought 30,000 shares of Peak Bio, Inc.17
- Sep 12, 2023Bought 17,000 shares of Peak Bio, Inc.18
- Sep 11, 2023Bought 30,000 shares of Peak Bio, Inc.18
- Aug 31, 2023Bought of Peak Bio, Inc.19
- Aug 31, 2023Bought 13,000 shares at $0.27 of Peak Bio, Inc.20
- Aug 30, 2023Bought of Peak Bio, Inc.19
- Aug 30, 2023Bought 56,100 shares at $0.26 of Peak Bio, Inc.20
- Aug 30, 2023Bought of Peak Bio, Inc.19
- Aug 30, 2023Bought 11,400 shares at $0.27 of Peak Bio, Inc.20
- Aug 30, 2023Bought of Peak Bio, Inc.19
- Aug 30, 2023Bought 3,750 shares at $0.25 of Peak Bio, Inc.20
- Aug 30, 2023Bought of Peak Bio, Inc.19
- Aug 30, 2023Bought 2,500 shares at $0.26 of Peak Bio, Inc.20
- Aug 30, 2023Bought of Peak Bio, Inc.19
- Aug 30, 2023Bought 1,000 shares at $0.25 of Peak Bio, Inc.20
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAkari Therapeutics Plc, Board member
- 2SEC EDGARPliant (United States), Board member
- 3SEC EDGARPeak Bio, Inc., Board member
- 4
- 5SEC EDGARGeron Corporation, Board member
- 6SEC EDGARRezolute, Inc., Chair
- 7SEC EDGARRezolute, Inc., Board member
- 8SEC EDGARGeron Corporation, Chair
- 9SEC EDGARNektar Therapeutics, Board member
- 10
- 11
- 12
- 13SEC EDGARForm 4 filed Mar 10, 2025
- 14SEC EDGARForm 4 filed Sep 25, 2023
- 15SEC EDGARForm 4 filed Sep 21, 2023
- 16SEC EDGARForm 4 filed Sep 19, 2023
- 17SEC EDGARForm 4 filed Sep 15, 2023
- 18SEC EDGARForm 4 filed Sep 13, 2023
- 19SEC EDGARForm 4 filed Sep 12, 2023
- 20SEC EDGARForm 4 filed Sep 1, 2023